Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Labcorp Holdings Inc.

Labcorp Holdings Inc. (LH) Stock Overview

Explore Labcorp Holdings Inc.’s financial performance, market position, analyst ratings, and future outlook.

LH●NYSE
HealthcareMedical - Diagnostics & Research
$313.96
$1.62(0.52%)
U.S. Market opens in 13h 59m

Labcorp Holdings Inc. (LH)

Meyka AI Score

Z

Key Financials

Market Cap25.7B
P/E Ratio25.82
EPS (TTM)$16.85
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$297.46
3 Months$287.62
1 Year Target$269.39

LH Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Labcorp Holdings Inc. (NYSE: LH) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Labcorp Holdings Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LH on the NYSE shows an RSI of 69.26, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $269.39 for the NYSE listing.

Key metrics behind Labcorp Holdings Inc.'s NYSE-traded stock include a P/E ratio of 25.82 and a market capitalization of 25.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LH on the NYSE.

Price Performance (NYSE: LH)

1-Day Change
0.49%
5-Day Change
0.48%
1-Month Change
10.36%
3-Month Change
22.06%
6-Month Change
12.81%
Year-to-Date (YTD) Change
25.10%
1-Year Change
19.12%
3-Year Change
46.39%
5-Year Change
22.22%
All-Time (Max) Change
1398.85%

Contact Information

https://www.labcorp.com
336 229 1127
358 South Main Street, Burlington, NC, 27215

Company Facts

710,000 Employees
IPO DateMar 29, 1990
CountryUS
Actively Trading

Frequently Asked Questions